Kotian, S., Zhang, L., Boufraqech, M., Gaskins, K., Gara, S. K., Quezado, M., . . . Kebebew, E. (2017). Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways with CUDC-907 Inhibits Thyroid Cancer Growth and Metastases. Clin Cancer Res.
Citação norma ChicagoKotian, Shweta, Lisa Zhang, Myriem Boufraqech, Kelli Gaskins, Sudheer Kumar Gara, Martha Quezado, Naris Nilubol, and Electron Kebebew. "Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways With CUDC-907 Inhibits Thyroid Cancer Growth and Metastases." Clin Cancer Res 2017.
ציטוט MLAKotian, Shweta, et al. "Dual Inhibition of HDAC and Tyrosine Kinase Signaling Pathways With CUDC-907 Inhibits Thyroid Cancer Growth and Metastases." Clin Cancer Res 2017.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.